Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome

Obstetrics and Gynecology

Volumn 98, Issue 2, 2001, Pages 235-242

  Venkat Raman, N ^a   Backos, May ^a   Teoh, T G ^a   Lo, W T S ^a   Regan, Lesley ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER FLOWMETER; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PULSE WAVE; RECURRENT ABORTION; SCREENING TEST; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; UTERINE ARTERY;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; ARTERIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LUPUS COAGULATION INHIBITOR; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; PULSATILE FLOW; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERUS;

EID: 0034881072     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01460-0     Document Type: Article

References (22)

1. Antiphospholipid antibodies in pregnancy
2. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
3. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy
4. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies
5. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy
6. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview
7. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome
8. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome
9. Anticardiolipin antibodies in patients with recurrent pregnancy wastage: Treatment and uterine blood flow
10. Investigation of the uteroplacental circulation by Doppler ultrasound
11. Doppler study of uterine artery blood flow: Comparison of findings in the first and second trimesters of pregnancy
12. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?
13. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies
14. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
15. Uterine artery Doppler velocimetry as a screening test: Where we are and where we go
16. Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL)
17. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome
18. Heparin lowers blood pressure: Biological and clinical perspectives
19. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease
20. Altered vascular reactivity following partial nephrectomy in the rat: A possible mechanism of the blood-pressure-lowering effect of heparin
21. Heparin lowers blood pressure and vascular calcium uptake in hypertensive rats
22. Antihypertensive action of heparin: Role of the renin-angiotensin aldosterone system and prostaglandins